Circulating serum HBsAg level is a biomarker for HBV-specific T and B cell responses in chronic hepatitis B patients

Chronic hepatitis B (CHB) infection functional cure is defined as sustained loss of HBsAg and several therapeutic strategies are in clinical development designed to pharmacologically reduce serum HBsAg, break immune tolerance, and increase functional cure rates. However, little is known about pre-tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jin Hyang, Ghosh, Alip, Ayithan, Natarajan, Romani, Sara, Khanam, Arshi, Park, Jang-June, Rijnbrand, Rene, Tang, Lydia, Sofia, Michael J., Kottilil, Shyam, Moore, Chris B., Poonia, Bhawna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000714/
https://www.ncbi.nlm.nih.gov/pubmed/32020034
http://dx.doi.org/10.1038/s41598-020-58870-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000714/
https://www.ncbi.nlm.nih.gov/pubmed/32020034
http://dx.doi.org/10.1038/s41598-020-58870-2

Ejemplares similares